纳米技术在光热疗法基础上的协同免疫疗法的潜力:一篇综述
Xiao-Kai Chi1, Xiao Zhang2, Jin Su3
1Department of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, PR China.
Journal of nanobiotechnology
|November 29, 2025
概括
光热疗法 (PTT) 与免疫疗法相结合,在癌症治疗方面表现有前途. 这种方法利用PTT去除瘤并诱导免疫细胞死亡 (ICD),增强对癌症的免疫反应.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 癌症治疗超越了传统的化疗和放射治疗.
- 光热疗法 (PTT) 是一种新兴的非侵入性瘤切除策略.
- 瘤组织可以通过免疫细胞死亡 (ICD) 刺激抗瘤免疫力.
研究的目的:
- 审查基于纳米材料的PTT及其相关的ICD效应的最新进展.
- 探索扩大瘤微环境中的ICD效应的策略.
- 讨论PTT与免疫治疗的结合,以提高抗瘤疗效.
主要方法:
- 对基于纳米材料的PTT的当前文献的综述.
- 分析PTT诱导的ICD背后的机制.
- 检查涉及PTT和免疫治疗的组合策略.
主要成果:
- PTT可以诱导瘤切除,并有助于ICD.
- 免疫抑制性瘤微环境对PTT疗效构成了挑战.
- 将PTT与免疫疗法结合起来可以克服免疫抑制并改善结果.
结论:
- 基于纳米材料的PTT具有癌症治疗的巨大潜力.
- 加强ICD和将PTT与免疫疗法结合起来,对于最大限度地提高治疗效果至关重要.
- 未来的研究应该专注于开发有效的PTT组合疗法,以改善癌症治疗.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932
Microorganisms in Medicine and Therapeutics
917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


